Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Proteome Research

• Publication date

  2011-06-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/pr200238tPMID 21609022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.

  2011cited by this paper
• Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks.

  2010cited by this paper
• Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry.

  2010cited by this paper
• Scaffold: A bioinformatic tool for validating MS/MS‐based proteomic studies

  2010cited by this paper
• Differential Phosphoproteomics of Fibroblast Growth Factor Signaling: Identification of Src Family Kinase-Mediated Phosphorylation Events

  2010cited by this paper
• Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells

  2010cited by this paper
• Fyn

  2010cited by this paper
• Differential phosphorylation of the docking protein Gab1 by c-Src and the hepatocyte growth factor receptor regulates different aspects of cell functions

  2010cited by this paper
• The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.

  2010cited by this paper
• Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib‐resistant non‐small cell lung cancer cells with acquired MET amplification

  2010cited by this paper
• Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells

  2010cited by this paper
• Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.

  2009cited by this paper
• Src and FAK mediate cell–matrix adhesion‐dependent activation of met during transformation of breast epithelial cells

  2009cited by this paper
• Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition

  2009cited by this paper
• RAKing in AKT: A tumor suppressor function for the intracellular tyrosine kinase FRK

  2009cited by this paper
• Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.

  2009cited by this paper
• IDEAL-Q, an Automated Tool for Label-free Quantitation Analysis Using an Efficient Peptide Alignment Approach and Spectral Data Validation*

  2009cited by this paper
• NAViGaTOR: Network Analysis, Visualization and Graphing Toronto

  2009cited by this paper
• Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells

  2008cited by this paper
• HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.

  2008cited by this paper
• SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function.

  2008cited by this paper
• Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells.

  2008cited by this paper
• Global impact of oncogenic Src on a phosphotyrosine proteome.

  2008cited by this paper
• Signaling networks assembled by oncogenic EGFR and c-Met

  2008cited by this paper
• Unequal evolutionary conservation of human protein interactions in interologous networks

  2007cited by this paper
• Constitutive activation of c‐Met is correlated with c‐Met overexpression and dependent on cell–matrix adhesion in lung adenocarcinoma cell lines

  2007cited by this paper
• CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation.

  2007cited by this paper
• Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma

  2007cited by this paper
• Quantitative proteomic assessment of very early cellular signaling events

  2007cited by this paper
• Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks

  2007cited by this paper
• A curated compendium of phosphorylation motifs

  2007cited by this paper
• Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

  2006cited by this paper
• Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions

  2006cited by this paper
• Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)*S

  2006cited by this paper
• A probability-based approach for high-throughput protein phosphorylation analysis and site localization

  2006cited by this paper
• An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets

  2005cited by this paper
• Immunoaffinity profiling of tyrosine phosphorylation in cancer cells

  2005cited by this paper
• Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules*S

  2005cited by this paper
• Online Predicted Human Interaction Database

  2005cited by this paper
• A renaissance for SRC

  2004cited by this paper
• Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts

  2004cited by this paper
• RNA Interference Reveals that Ligand-Independent Met Activity Is Required for Tumor Cell Signaling and Survival

  2004cited by this paper
• Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis.

  2004cited by this paper
• Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics

  2004cited by this paper
• SRC gene expression in human cancer: the role of transcriptional activation.

  2004cited by this paper
• Subsets of the Major Tyrosine Phosphorylation Sites in Crk-associated Substrate (CAS) Are Sufficient to Promote Cell Migration*

  2004cited by this paper
• Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis

  2004cited by this paper
• Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.

  2003cited by this paper
• c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.

  2003cited by this paper
• Met, metastasis, motility and more

  2003cited by this paper
• A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.

  2003cited by this paper
• Activation of Src kinase in primary colorectal carcinoma

  2002cited by this paper
• Endocytosis of Epidermal Growth Factor Receptor Regulated by Grb2-mediated Recruitment of the Rab5 GTPase-activating Protein RN-tre*

  2002cited by this paper
• Scatter-factor and semaphorin receptors: cell signalling for invasive growth

  2002cited by this paper
• Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

  2002cited by this paper
• Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1.

  2001cited by this paper
• Differential MAPK Pathways Utilized for HGF- and EGF-dependent Renal Epithelial Morphogenesis*

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5

  2000cited by this paper
• Essential Role of Gab1 for Signaling by the C-Met Receptor in Vivo

  2000cited by this paper
• A src-related kinase in the brush border membranes of gastrointestinal cells is regulated by c-met.

  1999cited by this paper
• Phosphotyrosine (p-Tyr)-Dependent and -Independent Mechanisms of p190 RhoGAP-p120 RasGAP Interaction: Tyr 1105 of p190, a Substrate for c-Src, Is the Sole p-Tyr Mediator of Complex Formation

  1998cited by this paper
• c-Src Kinase Activity Is Required for Hepatocyte Growth Factor-induced Motility and Anchorage-independent Growth of Mammary Carcinoma Cells*

  1998cited by this paper
• Structures of Src-family tyrosine kinases.

  1997cited by this paper
• Activation of the Sire-family tyrosine kinase Hck by SH3 domain displacement

  1997cited by this paper
• Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers.

  1997cited by this paper
• Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

  1997cited by this paper
• Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases.

  1997cited by this paper
• Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.

  1996cited by this paper
• Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

  1996cited by this paper
• Modulation of the SH2 Binding Specificity and Kinase Activity of Src by Tyrosine Phosphorylation within Its SH2 Domain (*)

  1996cited by this paper
• Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.

  1995cited by this paper
• Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.

  1995cited by this paper
• A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

  1994cited by this paper
• Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.

  1994cited by this paper
• c-Yes tyrosine kinase activity in human colon carcinoma.

  1993cited by this paper
• Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

  1993cited by this paper
• The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells

  1993cited by this paper
• Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells.

  1993cited by this paper
• Site-specific differences in pp60c-src activity in human colorectal metastases.

  1993cited by this paper
• Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas.

  1992cited by this paper
• Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

  1991cited by this paper
• pp60c-src activation in human colon carcinoma.

  1989cited by this paper
• Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines.

  1987cited by this paper
• Activation of pp60c-src protein kinase activity in human colon carcinoma.

  1987cited by this paper
• Protein Tyrosine Kinases Associated with Human Malignancies a

  1987cited by this paper
• BIOINFORMATICS APPLICATIONS NOTE

  year unknowncited by this paper

• Targeting Colorectal Cancer Liver Metastasis Through Repurposing Metabolic and Immune Inhibitors : A Theoretical Study

  2025cites this paper
• Alzheimer's disease‐associated P460L variant of EphA1 dysregulates receptor activity and blood‐brain barrier function

  2024cites this paper
• Metastasis organotropism in colorectal cancer: advancing toward innovative therapies

  2023cites this paper
• MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors

  2023cites this paper
• Colorectal liver metastasis: molecular mechanism and interventional therapy

  2022cites this paper
• Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers.

  2022cites this paper
• TYK2 in Cancer Metastases: Genomic and Proteomic Discovery

  2021cites this paper
• Proximity proteomics reveal EPH tyrosine kinase receptors’ regulation of cell polarity and identify Par3 scaffold protein as a novel effector of EPH signaling

  2020cites this paper
• c-Met as a potential therapeutic target in triple negative breast cancer

  2020cites this paper
• EPH Receptor Tyrosine Kinases Regulate Epithelial Morphogenesis and Phosphorylate the PAR-3 Scaffold Protein to Modulate Downstream Signaling Networks

  2020cites this paper
• EPH tyrosine kinase receptors regulate epithelial morphogenesis and phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks

  2020cites this paper
• Signals Getting Crossed in the Entanglement of Redox and Phosphorylation Pathways: Phosphorylation of Peroxiredoxin Proteins Sparks Cell Signaling

  2019cites this paper
• 13 Molecular Mechanisms of Lymphatic Metastasis

  2018cites this paper
• Mechanism of Chinese herbal formula QHF against breast cancer MCF-7 cells invasion and migration

  2018cites this paper
• Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential

  2017cites this paper
• Biomarker discovery by proteomics‐based approaches for early detection and personalized medicine in colorectal cancer

  2017cites this paper
• Amplification and overexpression of the MET gene in intrahepatic cholangiocarcinoma correlate with adverse pathological features and worse clinical outcome

  2017cites this paper
• Extracellular matrix factors influence myoblast activation, differentiation and fusion.

  2015cites this paper
• Biology of MET: a double life between normal tissue repair and tumor progression.

  2015cites this paper
• Dose-dependent modulation of myogenesis by HGF: implications for c-Met expression and downstream signalling pathways

  2015cites this paper
• Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling

  2014cites this paper
• p120RasGAP Is a Mediator of Rho Pathway Activation and Tumorigenicity in the DLD1 Colorectal Cancer Cell Line

  2014cites this paper
• Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers

  2014cites this paper
• The molecular rationale of Src inhibition in colorectal carcinomas

  2014cites this paper
• c-MET and KRAS: Signalling and Clinical Implications in Colorectal Cancer

  2014cites this paper
• Profiling the Dynamics of a Human Phosphorylome Reveals New Components in HGF/c-Met Signaling

  2013cites this paper
• Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.

  2013cites this paper
• Quantitative mass spectrometry for colorectal cancer proteomics

  2013cites this paper
• KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.

  2013cites this paper
• c-MET overexpression as a prognostic biomarker in colorectal adenocarcinoma.

  2013cites this paper
• Molecular Mechanisms of Lymphatic Metastasis

  2012cites this paper
• Predictive molecular tools to personalized gastric cancer targeted therapy.

  2012cites this paper
• Therapeutic potential of c-MET inhibitors: background and clinical data

  2012cites this paper
• c-MET as a potential therapeutic target and biomarker in cancer

  2011cites this paper
• An overview of the c-MET signaling pathway

  2011cites this paper
• Method for identification of proteome

  2011cites this paper